Stacy Ku
Stock Analyst at TD Cowen
(1.32)
# 3,401
Out of 5,090 analysts
6
Total ratings
50%
Success rate
-1.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stacy Ku
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $45 → $60 | $45.68 | +31.35% | 1 | Oct 23, 2025 | |
| BCRX BioCryst Pharmaceuticals | Reinstates: Buy | $30 | $7.59 | +295.26% | 1 | Oct 15, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | n/a | $29.91 | - | 1 | Jan 7, 2025 | |
| KALV KalVista Pharmaceuticals | Initiates: Buy | $30 | $16.43 | +82.59% | 1 | Jan 7, 2025 | |
| VRCA Verrica Pharmaceuticals | Maintains: Buy | $150 → $100 | $8.81 | +1,035.07% | 1 | Oct 21, 2024 | |
| ATXS Astria Therapeutics | Initiates: Buy | $35 | $12.93 | +170.69% | 1 | Jul 29, 2024 |
Supernus Pharmaceuticals
Oct 23, 2025
Maintains: Buy
Price Target: $45 → $60
Current: $45.68
Upside: +31.35%
BioCryst Pharmaceuticals
Oct 15, 2025
Reinstates: Buy
Price Target: $30
Current: $7.59
Upside: +295.26%
Centessa Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: n/a
Current: $29.91
Upside: -
KalVista Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $30
Current: $16.43
Upside: +82.59%
Verrica Pharmaceuticals
Oct 21, 2024
Maintains: Buy
Price Target: $150 → $100
Current: $8.81
Upside: +1,035.07%
Astria Therapeutics
Jul 29, 2024
Initiates: Buy
Price Target: $35
Current: $12.93
Upside: +170.69%